Aziyo Biologics, Inc. - Class A
News
Cantor Fitzgerald Reaffirms Overweight Rating for Aziyo Biologics (NASDAQ:AZYO)
Zolmax Cantor Fitzgerald reissued their overweight rating on shares of Aziyo Biologics (NASDAQ:AZYO Free Report) in a research report report published on Tuesday , Benzinga reports. The firm currently has a $8.00 price objective on the stock. Cantor Fitzgerald also issued estimates for Aziyo Biologics ...\n more…
Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company
Globe Newswire Negotiating multiple LOIs to divest Orthopedic business CanGaroo RM 510(k) resubmission to the FDA remains on track SimpliDerm quarterly net sales up 32% year-over-year Successful transfer of Cardiovascular product distribution to LeMaitre Vascular SILVER SPRING, Md., Aug. 14, 2023 (GLOBE NEWSWIRE...\n more…
Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
Globe Newswire SILVER SPRING, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (Aziyo), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today announced that it will release its second quarter ...\n more…
Contrasting Aziyo Biologics (NASDAQ:AZYO) & Aptose Biosciences (NASDAQ:APTO)
Ticker Report Aziyo Biologics (NASDAQ:AZYO Get Free Report) and Aptose Biosciences (NASDAQ:APTO Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, ...\n more…
This company keeps selling TB-tainted bone grafts, causing deadly outbreaks
Ars Technica In the last outbreak, at least 87 people had signs of tuberculosis after spinal surgery.\n\n Mycobacterium tuberculosis bacteria, which cause TB.">\n Scanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. (credit: National Institute of Allergy and Infectious Diseases)\n\nFor...\n more…